日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients

在肝移植受者中,第三剂BNT162b2 mRNA疫苗可显著提高对SARS-CoV-2变异株的中和活性。

Takahiro Tomiyama,Rigel Suzuki,Noboru Harada,Tomokazu Tamura,Katsuya Toshida,Yukiko- Kosai-Fujimoto,Takahiro Tomino,Shohei Yoshiya,Yoshihiro Nagao,Kazuki Takeishi,Shinji Itoh,Nobuhiro Kobayashi,Hayato Ito,Sachiyo Yoshio,Tatsuya Kanto,Tomoharu Yoshizumi,Takasuke Fukuhara

Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma

癌症相关成纤维细胞通过 miR-493-5p 促进肝内胆管癌中的肿瘤细胞生长

Katsuya Toshida, Shinji Itoh, Noboru Harada, Akinari Morinaga, Kyohei Yugawa, Takahiro Tomiyama, Yukiko Kosai-Fujimoto, Takahiro Tomino, Takeshi Kurihara, Yoshihiro Nagao, Kazutoyo Morita, Yoshinao Oda, Tomoharu Yoshizumi

Transferrin Receptor is Associated with Sensitivity to Ferroptosis Inducers in Hepatocellular Carcinoma

转铁蛋白受体与肝细胞癌对铁死亡诱导剂的敏感性有关

Maki Hiromatsu #, Katsuya Toshida #, Shinji Itoh, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Tomoharu Yoshizumi

Clinical significance of mechanistic target of rapamycin expression in vessels that encapsulate tumor cluster-positive hepatocellular carcinoma patients who have undergone living donor liver transplantation

接受活体肝移植的肝细胞癌患者肿瘤簇阳性血管内雷帕霉素靶点表达的临床意义

Katsuya Toshida, Shinji Itoh, Takeo Toshima, Shohei Yoshiya, Ryoichi Goto, Atsuyoshi Mita, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Tomoharu Yoshizumi

Impact of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status

核因子红细胞2相关因子2对肝细胞癌的影响:癌症代谢和免疫状态

Norifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, Akinari Morinaga, Kyohei Yugawa, Masahiro Shimokawa, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Yoshiyuki Kitamura, Yoshihiro Nagao, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Shingo Baba, Kousei Ishigami, Yoshinao Oda,

Up-regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation

上调 LRRN2 表达作为活体肝移植中移植物质量的标志

Takahiro Tomiyama, Takuya Yamamoto, Shokichi Takahama, Takeo Toshima, Shinji Itoh, Noboru Harada, Mototsugu Shimokawa, Daisuke Okuzaki, Masaki Mori, Tomoharu Yoshizumi

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma

仑伐替尼通过抑制成纤维细胞生长因子受体 4 诱导肝细胞癌铁死亡

Norifumi Iseda, Shinji Itoh, Katsuya Toshida, Takahiro Tomiyama, Akinari Morinaga, Masahiro Shimokawa, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Takeo Toshima, Yoshihiro Nagao, Noboru Harada, Tomoharu Yoshizumi, Masaki Mori

Low syntaxin 17 expression in donor liver is associated with poor graft prognosis in recipients of living donor liver transplantation

供体肝脏中突触素 17 表达水平低与活体肝移植受体的移植预后不良相关

Takahiro Tomiyama, Masahiro Shimokawa, Noboru Harada, Katsuya Toshida, Akinari Morinaga, Yukiko Kosai-Fujimoto, Takahiro Tomino, Takeshi Kurihara, Yoshihiro Nagao, Takeo Toshima, Kazutoyo Morita, Shinji Itoh, Tomoharu Yoshizumi

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma

髓系抑制细胞浸润与肝细胞癌患者预后不良有关

Takahiro Tomiyama, Shinji Itoh, Norifumi Iseda, Katuya Toshida, Akinari Morinaga, Kyohei Yugawa, Yukiko Kosai Fujimoto, Takahiro Tomino, Takeshi Kurihara, Yoshihiro Nagao, Kazutoyo Morita, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Masaki Mori, Tomoharu Yoshizumi

Impact of JMJD6 on intrahepatic cholangiocarcinoma

JMJD6对肝内胆管癌的影响

Yukiko Kosai-Fujimoto, Shinji Itoh, Kyohei Yugawa, Takasuke Fukuhara, Daisuke Okuzaki, Takeo Toshima, Noboru Harada, Yoshinao Oda, Tomoharu Yoshizumi, Masaki Mori